QA: Hoth Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001711786_2023_Hoth_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001711786, Hoth Therapeutics Inc.

  xvar xval
0 AssetsCurrent 6,726,381
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 33,000
4 LiabilitiesCurrent 1,387,731
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 250,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 4,844,578
10 remainder_Expenses 6,220,976
11 remainder_Revenues 0
12 remainder_NetIncome -306,399
13 remainder_ComprehensiveNetIncome 4,420
  yvar yval
0 Assets 6,759,381
1 Liabilities 1,637,731
2 Expenses 11,065,554
3 Revenues 0
4 StockholdersEquity 5,121,650
5 NetIncome -11,371,953
6 ComprehensiveNetIncome -11,369,743
7 BaseVar 9,886,742
8 EconomicCapitalRatio -0.610

Edgar->Model Mapping

Feature Distribution

Change over Time